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ABSTRACT 
 Objective .In the present study, biocom[patible polymer chitosan  stabilized ofloxacin- gold nanoconjugate was  synthesized  for the improved anti 
bacterial activity against clinical isolate of  E.coli and Staphylococcus aureus  
Methods. Chitosan stabilized oflaxacin-gold nanoparticles conjugate was prepared with aqueous solution of ofloxacin ,gold nanoparticles 
suspension  and chitosan under optimum condition. Synthesized nanoconjugate was .characterized by  scanning electron microscopy, FTIR and the 
synthesized nanoconjugate was tested against E.coli and Staph.aureus adopting well diffusion assay.  
Result. Synthesis of chitosan stabilized ofloxacin- gold nanoconjugate was primarly confirmed by colour change of the reaction mixture, 
characteristic change in the FTIR pattern and  size and shape by SEM. Anti bacterial activity revealed increased spectrum of antibacterial activity 
was recorded in chitosan stabilized ofloxacin - gold nanoconjugate against both the tested strains.  The highest increase in inhibitory zone for E.coli 
and Staph.aureus was observed. 
Conclusion. The present study suggests possible utilization of antibiotics –gold nanoconjugate as an effective anti microbial agent against the 
pathogenic bacteria 
Keywords: chitosan,ofloxacin,nanoconjugate ,E.coli, Staphylococcus aureus   
 INTRODUCTION 
Nanobiotechnology is a branch of biotechnology which deals with 
the study and application of biological and biochemical activities 
from elements of nature to fabricate new devices like biosensors. 
The term bionanotechnology is often used interchangeably with 
nanobiotechnology, though a distinction is sometimes drawn 
between the two. If the two are distinguished, Nanobiotechnology 
usually refers to the use of nanotechnology to further the goals of 
biotechnology, while bionanotechnology might refer to any overlap 
between biology and Nanotechnology, including the use of 
biomolecules as part of or as an inspiration for Nanotechnological 
devices[1).The application of nanoscale materials and structures, 
usually ranging from 1 to 100 nanometers (nm), is an emerging area 
of nanoscience and nanotechnology. Nanomaterials may provide 
solutions to technological and environmental challenges in the areas 
of solar energy conversion, catalysis, medicine, and water treatment 
[2,3]. Nanoparticles can be used to treat diseases that require a 
sustained presence of the drug at several anatomical sites [4]. 
Nanomaterials are of interest to defense and engineering programs 
because of their potential use in electronics, sensors, munitions, and 
energetic/reactive systems involved in the advancement of 
propulsion technology[5].  If formulated properly with other 
materials, nanomaterials may provide greater stability and efficiency 
for propellant system, and can pass through biological membranes, 
they can affect the physiology of any cell in an animal 
body[6,7].Different types of nanomaterials like 
copper,zinc,titanium,magnesium, gold[8,9]  and silver have come up 
but silver nanoparticles have proved to be most effective as it has 
good antimicrobial efficacy against bacteria, viruses and other 
eukaryotic micro-organisms[10].In addition to silver nano, gold 
nanoparticles are also an obvious choice due to their amenability of 
synthesis and functionalization, less toxicity,ease of detection and  
compatibility with antibiotics[11]. In the present study, enhanced 
antibacterial activity of chitosan coated ofloxacin–gold 
nanoconjugate against clinical isolate of E.coli and Staphylococcus 
aureus was studied. 
MATERIALS AND METHODS 
Synthesis and characterization of free gold nanoparticles 
 
 
Gold nanoparticles were synthesized by chemical reduction of 
0.01% aqueous tetrachloroauric acid with 10ml 0f 1% aqueous 
sodium citrate Synthesis of gold nanoparticles was confirmed by the 
conversion of the reaction mixture into deep pink colour and further 
characterization of the synthesized gold nanoparticles was carried 
out with determination of Plasmon absorption maxima with UV-Vis 
spectroscopy, particle morphology (i.e., shape and size) with 
Transmission Electron Microscopy (TEM) and FT-IR analysis. 
Antibacterial activity of free gold nanoparticles 
The antibacterial activity of free gold nanoparticles was tested 
against pathogenic bacteria Escherichia coli and Staphylococcus 
aureus which were obtained from Chrompet general hospital, 
Chennai. The strains were maintained on nutrient agar slants. The 
inoculum was prepared in Nutrient broth. After 24 hours, the 
inoculum was spread with sterile cotton swab on Nutrient agar 
plates. Wells (8mm) were made using sterilized cork borer and 
0.0025mg/ml, 0.0050mg/ml, 0.0075mg/ml and 0.0100mg/ml of 
different concentration of silver nanoparticles were added 
separately. Similarly, different concentration (i.e., 0.00125mg/ml, 
0,00250mg/ml, 0.00375mg/ml and 0.00500mg/ml) of gold 
nanoparticles were added to each well. The seeded plates were 
incubated at 370C for 24 hours and the plates were observed for 
zone of inhibition. After the incubation period, the diameter of the 
zone was recorded. 
Preparation and Characterization of chitosan stabilized 
ofloxacin- gold nanoconjugate 
Chitosan was obtained from Rolex chemical industries, Mumbai and 
refined twice by dissolving it in dilute HOAc solution. The solution 
was filtered, the chitosan was precipitated with aqueous sodium 
hydroxide, and the precipitate was dried in vacuum at room 
temperature [12].The degree of deacetylation was about 85% as 
determined by elemental analysis, and the average molecular weight 
of the chitosan was 220kDa as determined by viscometric 
methods[13]. Chitosan stabilized ofloxacin-gold nanoparticles 
conjugate were prepared with aqueous solution of ofloxacin with the 
concentration of 3mg, 0.0025mg/ml, 0.0050mg/ml, 0.0075mg/ml  
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and 0.00125mg/ml, 0,00250mg/ml, 0.00375mg/ml and 
0.00500mg/ml) of gold nanoparticles were mixed with 0.2% 
chitosan solution. The mixture was stirred under magnetic stirrer 
for 3hrs to get the complete homogenous mixture. The slurry thus 
obtained was freeze dried and used for further studies. 
Characterisation of nanoparticles loaded antibiotics was carried out 
with FT-IR, Scanning electron microscope (SEM) and Energy 
Dispersive X-Ray Spectroscopy (EDX) used for quantitative detection 
and localization of elements in the nano specimens. 
Evaluation of antibacterial activity of chitosan stabilized  
ofloxacin –gold nanoconjugate 
Synthesized nanoconjugate thus prepared were dissolved in 
deionized water with different concentration and  evaluated against 
tested bacteria by well diffusion method as described earlier. 
RESULT AND DISCUSSION 
Synthesis of gold nanoparticles was confirmed by colour change of 
the reaction mixture to pink colour and broad surface Plasmon peak 
located at 520nm, particle size and shape with Transmission 
Electron microscope (TEM) as spherical particles with the size range 
of 25-50nm (Figour 1). 
 
Figure 1: TEM image of synthesized gold nanoparticle 
Antibacterial activity was not recorded in free gold nanoparticles. No 
zone of inhibition was observed in all the tested concentration such 
as 0.00125mg/ml, 0.00250mg/ml, 0.00375mg/ml and 
0.00500mg/ml of gold nanoparticles (AuNPs) against both the 
tested strains (Table 1,2). 
Table 1: shows 
Sl. No  Concentration 
(mg/ml)  
Zone of inhibition 
(mm)  
1.  0.00125  00  
2.  0.00250  00  
3.  0.00375  00  
4.  0.00500  00  
Table 2:  shows 
Sl. No  Concentration 
(mg/ml)  
Zone of inhibition 
(mm)  
1.  0.00125  00  
2.  0.00250  00  
3.  0.00375  00  
4.  0.00500  00  
Antibiogram of the free ofloxacin revealed  both the tested strains 
were susceptible and the zone of inhibition was increased  as dose 
dependent manner. Maximum zone of inhibition was recorded in 
1mg/ml and 0.01mg/ml as 38 and 36mm (Table 3,4) 
Table 3:  shows 
Sl. No Concentration  
(mg/ml) 
Zone of inhibition 
(mm) 
1. 0.25 34 
2. 0.50 37 
3. 0.75 39 
4. 1.00 41 
5. 0.025 32 
6. 0.050 34 
7. 0.075 37 
8. 0.100 39 
9. 0.0025 30 
10. 0.0050 32 
11. 0.0075 35 
12. 0.0100 33 
13. 0.0050 32 
14. 0.0100 34 
15. 0.0150 36 
16. 0.0200 39 
17. 0.0075 31 
18. 0.0150 34 
19. 0.0225 37 
20. 0.0300 39 
21. 0.0025 27 
22. 0.0050 31 
23. 0.0075 34 
24. 0.0100 37 
25. 0.00125 23 
26. 0.00250 26 
27. 0.00375 30 
28. 0.00500 32 
29. 0.00025 19 
30. 0.00050 22 
31. 0.00075 25 
32. 0.00100 28 
33. 0.0003 20 
34. 0.0006 26 
35. 0.0015 28 
36. 0.003 30 
37. 0.0045 32 
38. 0.006 34 
39. 0.00015 16 
40. 0.0003 20 
41. 0.00075 23 
42. 0.0015 25 
43. 0.00225 28 
44. 0.003 30 
45. 0.00003 00 
46. 0.00006 10 
47. 0.00015 18 
48. 0.0003 21 
49. 0.00045 23 
50. 0.0006 25 
Table 4: shows 
Sl. No Concentration  
(mg/ml) 
Zone of inhibition 
(mm) 
1. 0.25 32 
2. 0.50 35 
3. 0.75 37 
4. 1.00 40 
5. 0.025 30 
6. 0.050 34 
7. 0.075 36 
8. 0.100 40 
9. 0.0025 24 
10. 0.0050 26 
11. 0.0075 29 
12. 0.0100 31 
13. 0.0050 27 
14. 0.0100 30 
15. 0.0150 33 
16. 0.0200 36 
17. 0.0075 30 
18. 0.0150 33 
19. 0.0225 35 
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20. 0.0300 38 
21. 0.0025 21 
22. 0.0050 27 
23. 0.0075 30 
24. 0.0100 34 
25. 0.00125 20 
26. 0.00250 24 
27. 0.00375 27 
28. 0.00500 32 
29. 0.00025 19 
30. 0.00050 23 
31. 0.00075 27 
32. 0.00100 29 
33. 0.0015 17 
34. 0.003 21 
35. 0.0045 24 
36. 0.006 30 
37. 0.00075 14 
38. 0.0015 19 
39. 0.00225 23 
40. 0.003 27 
41. 0.00015 00 
42. 0.0003 00 
43. 0.00045 00 
44. 0.0006 00 
 No zone of inhibition was observed in 0.00003mg/ml and 
0.00006mg/ml for E-coli. In Staph.aureus, 1mg/ml and 0.75mg/ml 
reveals distinct antibacterial activity with the zone of inhibition of 
41 and 37mm respectively, no zone of inhibition was observed in 
0.00015mg/ml Chitosan stabilized ofloxacin-gold nanoparticles 
conjugate was primarily confirmed by colour change of the reaction 
mixture from dark pink to pale yellow. The scanning electron 
microscopy study reveals chitosan stabilized ofloxacin- gold 
nanoparticles as spherical particles with the size range of 20 to 
40nm (Figour 2).. The SEM analyzer built-in with an EDAS micro-
analyzer allows a quantitative detection and localization of elements 
in the nano specimens. EDAS images showed the presence of 
elements like carbon, oxygen, nitrogen and gold in the range of 
49.96, 43.17, 4.34 and 2.72% respectively ( Figour  3). 
 



















Figure 3: Energy dispersive spectroscopy (EDS) of chitosan 
stabilized  ofloxacin gold nanoconjugate 
The profiles of FT-IR spectroscopy reveals the main absorption of 
chitosan stabilized ofloxacin- gold nanoparticles at 3465.62cm-1, 
2368.47cm-1, 2082.66 cm-1, 1638.08 cm-1 and 695.67 cm-1. When 
the FTIR spectrum of  chitosan stabilized  gold-ofloxacin were 
compared, it was found that almost the all the absorbed peaks were 
modified upon stabilization with chitosan(Figure 4,5). 
 
 
Figure  4: FTIR spectra of  gold nanoparticles 
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It can be seen that the chitosan stabilized antibiotic nanoparticles 
conjugate retarded bacterial growth to a degree comparable to that 
demonstrated by the free antibiotic. When the free antibiotic 
conjugated with nanoparticles the diameter of the zone of inhibition 
were increased by at least two folds. Chitosan Stabilized ofloxacin-
gold nanoparticles showed distinct increase in antibacterial activity 
against both the tested strain(Table 5,6).  
 
Table 5: shows 
Sl. No  Ofloxacin AuNPs  Ofloxacin + AuNPs  
Concentration  
(mg/ml)  








Zone of inhibition  
(mm)  
1.        0.00015         10  0.00125  00  0.00015 + 0.00125  25  
2.        0.0003  15  0.00250  00  0.0003   + 0.00250  35  
3.        0.00045  18  0.00375  00  0.00045 + 0.00375  37  
4.        0.0006  20  0.00500  00  0.0006   + 0.00500  40  
 
Table 6: shows 
 
 Sl. No  AuNPs  Ofloxacin + AuNPs  
Concentration  
(mg/ml)  








Zone of inhibition  
(mm)  
1.        0.00015         00  0.00125  00  0.00015 + 0.00125  20  
2.        0.0003  14  0.00250  00  0.0003   + 0.00250  31  
3.        0.00045  17  0.00375  00  0.00045 + 0.00375  38  
4.        0.0006  22  0.00500  00  0.0006   + 0.00500  47  
 
In E-coli the maximum inhibitionwas recorded in 
0.00015+0.00125mg/ml,0.0003+0.00250mg/ml, 
0.00045+0.00375mg/ml and 0.0006+0.00500mg/ml Concentration 
with the zone of inhibition of 25, 35, 37 and 40mm.Similar improved 
activity of nanoconjugate against Staphylococcus aureus was 
recorded in 0.00015+ 0.00125mg/ml, 0.0003+0.00250mg/ml, 
0.00045+0.00375mg/ml, 0.0006+0.00500mg/ml Concentration 
with the zone of inhibition of 20, 31, 38 and 47mm In the present 
study ,chitosan stabilized ofloxacin gold nanoparticles recorded 
enhanced antibacterial activity against both the tested strains. 
Similar findings has been reported by Namasivayam et al [14,15]. 
Anti bacterial activity of oflaxacin and tetracycline was found to be 
increased  with silver nanoparticles. Burygin et al[16] studied 
enhanced antibacterial activity of gentamycin -gold nanoparticles.  
Various polymers are now used  to stabilize the metallic 
nanoparticles. Chitosan is the natural polymer has been reported as 
a polymer-based protective agent to stabilize the metal 
nanoparticles[17].Because of the biocompatibility,biodegradability, 
nontoxicity and adsorption properties of chitosan, it was used as a 
stabilizing agent to prepare Ag, Au and Pt nanoparticles. These 
chitosan- protected nanoparticles can be easily integrated into 
systems relevant for pharmaceutical, biomedical, and biosensor 
applications. Therefore, it has attracted considerable interest due to 
its medicinal properties, such as antifungal, antibacterial, 
antiprotozoal, anticancer, antiplaque, antitartar, hemostatic, wound 
healing and potentiates anti-inflammatory response, inhibits the 
growth of cariogenic bacteria, immunopotentiation, 
antihypertensive, serum cholesterol lowering, immune enhancer, 
increases salivary secretion (anti-xerostomial) and helps in the 
formation of bone substitute materials[18].The present study 
reveals the enhanced anti bacterial effect of  chitosan stabilized  
ofloxacin gold nanoconjugate against clinical isolate of E.coli and 
Staphylococcus aureus would suggests the possible utilization of 
nanoparticles as the antimicrobial agents. 
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